Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: May, 2015 | Pages:
36 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
BioInvent International AB - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'BioInvent International AB - Product Pipeline Review - 2015', provides an overview of the BioInvent International AB's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of BioInvent International AB's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of BioInvent International AB including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of BioInvent International AB's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the BioInvent International AB's pipeline products Reason to Buy - Evaluate BioInvent International AB's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of BioInvent International AB in its therapy areas of focus - Identify new drug targets and therapeutic classes in the BioInvent International AB's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of BioInvent International AB and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of BioInvent International AB - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of BioInvent International AB and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 BioInvent International AB Snapshot 5 BioInvent International AB Overview 5 Key Information 5 Key Facts 5 BioInvent International AB - Research and Development Overview 6 Key Therapeutic Areas 6 BioInvent International AB - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Pipeline Products - Out-Licensed Products 12 Out-Licensed Products/Combination Treatment Modalities 13 BioInvent International AB - Pipeline Products Glance 14 BioInvent International AB - Clinical Stage Pipeline Products 14 Phase II Products/Combination Treatment Modalities 14 BioInvent International AB - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 BioInvent International AB - Drug Profiles 17 BI-505 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 BI-1206 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Monoclonal Antibodies for Acute Myelocytic Leukemia 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Monoclonal Antibodies for Blood Cancers 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Monoclonal Antibodies for Chronic Lymphocytic Leukemia 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Monoclonal Antibodies to Agonize 41BB for Cancer 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Monoclonal Antibodies to Agonize OX40 for Cancer 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Monoclonal Antibodies to Target Tumour-Associated Macrophages for Cancer 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Monoclonal Antibody for Inflammation 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 BioInvent International AB - Pipeline Analysis 26 BioInvent International AB - Pipeline Products by Target 26 BioInvent International AB - Pipeline Products by Route of Administration 27 BioInvent International AB - Pipeline Products by Molecule Type 28 BioInvent International AB - Pipeline Products by Mechanism of Action 29 BioInvent International AB - Recent Pipeline Updates 30 BioInvent International AB - Company Statement 32 BioInvent International AB - Locations And Subsidiaries 34 Head Office 34 Other Locations & Subsidiaries 34 Appendix 35 Methodology 35 Coverage 35 Secondary Research 35 Primary Research 35 Expert Panel Validation 35 Contact Us 35 Disclaimer 36
List of Tables
BioInvent International AB, Key Information 5 BioInvent International AB, Key Facts 5 BioInvent International AB - Pipeline by Indication, 2015 7 BioInvent International AB - Pipeline by Stage of Development, 2015 8 BioInvent International AB - Monotherapy Products in Pipeline, 2015 9 BioInvent International AB - Partnered Products in Pipeline, 2015 10 BioInvent International AB - Partnered Products/ Combination Treatment Modalities, 2015 11 BioInvent International AB - Out-Licensed Products in Pipeline, 2015 12 BioInvent International AB - Out-Licensed Products/ Combination Treatment Modalities, 2015 13 BioInvent International AB - Phase II, 2015 14 BioInvent International AB - Preclinical, 2015 15 BioInvent International AB - Discovery, 2015 16 BioInvent International AB - Pipeline by Target, 2015 26 BioInvent International AB - Pipeline by Route of Administration, 2015 27 BioInvent International AB - Pipeline by Molecule Type, 2015 28 BioInvent International AB - Pipeline Products by Mechanism of Action, 2015 29 BioInvent International AB - Recent Pipeline Updates, 2015 30 BioInvent International AB, Subsidiaries 34
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
